Vasculogenesis and Angiogenesis as Mechanisms of Vascular Network Formation, Growth and Remodeling

Two distinct mechanisms, vasculogenesis and angiogenesis implement the formation of the vascular network in the embryo. Vasculogenesis gives rise to the heart and the first primitive vascular plexus inside the embryo and in its surrounding membranes, as the yolk sac circulation. Angiogenesis is responsible for the remodeling and expansion of this network. While vasculogenesis refers to in situ differentiation and growth of blood vessels from mesodermal derived hemangioblasts, angiogenesis comprises two different mechanisms: endothelial sprouting and intussusceptive microvascular growth (IMG). The sprouting process is based on endothelial cell migration, proliferation and tube formation. IMG divides existing vessel lumens by formation and insertion of tissue folds and columns of interstitial tissue into the vessel lumen. The latter are termed interstitial or inter-vascular tissue structures (ITSs) and tissue pillars or posts. Intussusception also includes the establishment of new vessels by in situ loop formation in the wall of large veins. The molecular regulation of these distinct mechanisms is discussed in respect to the most important positive regulators, vascular endothelial growth factor (VEGF) and its receptors flk-1 (KDR) and flt-1, the Angiopoietin/tie system and the ephrin-B/EpH-B system. The cellular mechanisms and the molecular regulation of angiogenesis in the pathological state are summarized and the differences of physiological and pathological angiogenesis elaborated.

[1]  G. Martiny-Baron,et al.  Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway. , 1999, Cancer research.

[2]  N. Bouck.  Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. , 1990, Cancer cells.

[3]  Mojmir R Tarek,et al.  A novel mechanism of capillary growth in the rat pulmonary microcirculation , 1990, The Anatomical record.

[4]  T J Poole,et al.  Vasculogenesis and angiogenesis: two distinct morphogenetic mechanisms establish embryonic vascular pattern. , 1989, The Journal of experimental zoology.

[5]  M. Dewhirst,et al.  Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie 2 ( cancer y adenovirus y soluble receptor y tumor angiogenesis ) , 1998 .

[6]  Eliot R. Clark,et al.  Studies on the growth of blood-vessels in the tail of the frog larva—by observation and experiment on the living animal , 1918 .

[7]  V. Danchakoff.  The position of the respiratory vascular net in the allantois of the chick , 1917 .

[8]  F. Becker,et al.  Growth and metastasis of tumor in organ culture , 1963, Cancer.

[9]  J. Folkman,et al.  Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. , 1984, Science.

[10]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[11]  J. Isner,et al.  Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. , 1998, Circulation research.

[12]  H. W. Chalkley,et al.  Vasculae Reactions of Normal and Malignant Tissues in Vivo. I. Vascular Reactions of Mice to Wounds and to Normal and Neoplastic Transplants , 1945 .

[13]  G. Yancopoulos,et al.  Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family. , 1993, Oncogene.

[14]  S. Patan,et al.  TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth. , 1998, Microvascular research.

[15]  J. Folkman.  Clinical Applications of Research on Angiogenesis , 1995 .

[16]  J. Isner,et al.  Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. , 1998, Circulation.

[17]  J. Folkman,et al.  A simple procedure for the long-term cultivation of chicken embryos. , 1974, Developmental biology.

[18]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[19]  J. Folkman,et al.  Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors , 1972, Annals of surgery.

[20]  K. Plate,et al.  Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system. , 1997, Cancer research.

[21]  Kenneth J. Hillan,et al.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.

[22]  E. Manseau,et al.  Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining. , 1995, Cancer research.

[23]  J. Folkman,et al.  ANGIOGENESIS: INITIATION AND CONTROL * , 1982, Annals of the New York Academy of Sciences.

[24]  A. C. G. Wenink,et al.  Myocardial capillaries: Increase in number by splitting of existing vessels , 2005, Anatomy and Embryology.

[25]  Eliot R. Clark,et al.  Microscopic observations on the growth of blood capillaries in the living mammal , 1939 .

[26]  L. DiPietro.  Thrombospondin as a regulator of angiogenesis. , 1997, EXS.

[27]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[28]  Urban Deutsch,et al.  Angiopoietin-1 induces sprouting angiogenesis in vitro , 1998, Current Biology.

[29]  S. Ziegler,et al.  Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta. , 1993, Oncogene.

[30]  A. G. Gittenberger-de Groot,et al.  Vascular endothelial cells migrate centripetally within embryonic arteries , 2004, Anatomy and Embryology.

[31]  G. Garcı́a-Cardeña,et al.  Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[32]  A. Iwama,et al.  Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells. , 1993, Biochemical and biophysical research communications.

[33]  K. Sakaguchi,et al.  Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth , 1998, The Journal of experimental medicine.

[34]  T. Collins,et al.  Regulation of PDGF-B in endothelial cells exposed to cyclic strain. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[35]  J. Partanen,et al.  Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. , 1992, Blood.

[36]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[37]  J. Ware,et al.  Angiogenesis in ischemic heart disease , 1997, Nature Medicine.

[38]  B. V. von Specht,et al.  Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. , 1998, Circulation.

[39]  C F Dewey,et al.  Shear stress gradients remodel endothelial monolayers in vitro via a cell proliferation-migration-loss cycle. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[40]  R. Short.  Alveolar epithelium in relation to growth of the lung , 1950, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences.

[41]  W. Risau.  Vasculogenesis, angiogenesis and endthelial cell differentiation during embryonic development , 1991 .

[42]  J. Folkman,et al.  Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. , 1977, Microvascular research.

[43]  Thomas N. Sato,et al.  Increased vascularization in mice overexpressing angiopoietin-1. , 1998, Science.

[44]  M. L. Le Beau,et al.  A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[45]  T Pawson,et al.  Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. , 1994, Science.

[46]  A. Amores,et al.  The cloche and spadetail genes differentially affect hematopoiesis and vasculogenesis. , 1998, Developmental biology.

[47]  F. Reagan,et al.  Vascularization phenomena in fragments of embryonic bodies completely isolated from yolk‐sac blastoderm , 1915 .

[48]  Pamela F. Jones,et al.  Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning , 1996, Cell.

[49]  J. Partanen,et al.  A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains , 1992, Molecular and cellular biology.

[50]  A. Ullrich,et al.  Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant , 1994, Nature.

[51]  B. Keyt,et al.  Identification of Vascular Endothelial Growth Factor Determinants for Binding KDR and FLT-1 Receptors , 1996, The Journal of Biological Chemistry.

[52]  A. Ullrich,et al.  Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. , 1996, Cancer research.

[53]  J. Folkman,et al.  Long-term culture of capillary endothelial cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Janet Rossant,et al.  A Requirement for Flk1 in Primitive and Definitive Hematopoiesis and Vasculogenesis , 1997, Cell.

[55]  K. Alitalo,et al.  Vascularization of the mouse embryo: A study of flk‐1, tek, tie, and vascular endothelial growth factor expression during development , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[56]  M. Taketo,et al.  TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. , 1996, Developmental biology.

[57]  Stuart K Williams,et al.  Capillary endothelial cell cultures: phenotypic modulation by matrix components , 1983, The Journal of cell biology.

[58]  M. McCarthy,et al.  The endothelial receptor tyrosine kinase tie‐1 is upregulated by hypoxia and vascular endothelial growth factor , 1998, FEBS letters.

[59]  E. Keshet,et al.  Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. , 1994, Cardiovascular research.

[60]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[61]  M. Gertsenstein,et al.  Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. , 1994, Genes & development.

[62]  W. Schaper,et al.  Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. , 1998, The Journal of clinical investigation.

[63]  M. Greenblatt,et al.  Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique. , 1968, Journal of the National Cancer Institute.

[64]  G. Martiny-Baron,et al.  Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. , 1997, Cancer research.

[65]  F. Sabin.  Studies on the origin of blood vessels and of red corpuscles as seen in the living blastoderm of the chick during the second day of incubation , 1920 .

[66]  J. Isner,et al.  Constitutive Expression of phVEGF 165 After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb Ischemia Clinical Investigation and Reports , 1998 .

[67]  D. Noden.  Embryonic origins and assembly of blood vessels. , 1989, The American review of respiratory disease.

[68]  P. Burri,et al.  Evidence for intussusceptive capillary growth in the chicken chorio-allantoic membrane (CAM) , 1993, Anatomy and Embryology.

[69]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[70]  Ziegler Sf,et al.  Molecular Cloning and Characterization of a Novel Receptor Protein Tyrosine Kinase From Human Placenta , 1993 .

[71]  Willem Flameng,et al.  Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 , 1999, Nature Medicine.

[72]  H. Schnürch,et al.  Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. , 1993, Development.

[73]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[74]  David J. Anderson,et al.  Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4 , 1998, Cell.

[75]  N. Douarin.  Cell migrations in embryos , 1984, Cell.

[76]  J. Folkman,et al.  How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. , 1986, Cancer research.

[77]  Friedrich-Wilhelms-Universität Berlin,et al.  Beitr©Þge zur Entwicklung der Allantois der V©œgel. , 1895 .

[78]  J. Folkman,et al.  Tumor growth and neovascularization: an experimental model using the rabbit cornea. , 1974, Journal of the National Cancer Institute.

[79]  J. Rossant,et al.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium , 1995, Nature.

[80]  P. Burri,et al.  Intussusceptive microvascular growth: a common alternative to capillary sprouting. , 1992, Archives of histology and cytology.

[81]  J. Rossant,et al.  The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. , 1995, The EMBO journal.

[82]  F. Diella,et al.  Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. , 1999, Genes & development.

[83]  Thomas N. Sato,et al.  Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation , 1995, Nature.

[84]  R. Langer,et al.  Polymers for the sustained release of proteins and other macromolecules , 1976, Nature.

[85]  P. Burri,et al.  Implementation of intussusceptive microvascular growth in the chicken chorioallantoic membrane (CAM): 1. pillar formation by folding of the capillary wall. , 1996, Microvascular research.

[86]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[87]  P. Burri,et al.  Implementation of intussusceptive microvascular growth in the chicken chorioallantoic membrane (CAM). , 1997, Microvascular research.

[88]  William Arbuthnot Sir Lane,et al.  Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. , 1999, Science.

[89]  I. Flamme.  Is extraembryonic angiogenesis in the chick embryo controlled by the endoderm? , 1989, Anatomy and Embryology.

[90]  K Walsh,et al.  Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. , 1998, Circulation.

[91]  J. Isner,et al.  Chemotactic Properties of Angiopoietin-1 and -2, Ligands for the Endothelial-specific Receptor Tyrosine Kinase Tie2* , 1998, The Journal of Biological Chemistry.

[92]  N. Ferrara,et al.  Role of Vascular Endothelial Growth Factor in Regulation of Angiogenesis , 1999 .

[93]  Lieve Moons,et al.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.

[94]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[95]  Thomas Boehm,et al.  Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.

[96]  Judah Folkman,et al.  Angiogenesis in vitro , 1980, Nature.

[97]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[98]  R. Jain,et al.  Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis. , 1996, Microvascular research.

[99]  Peter J. Polverini,et al.  Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene , 1989, Cell.

[100]  J. Rossant,et al.  Multiple developmental roles of VEGF suggested by a LacZ-tagged allele. , 1999, Developmental biology.

[101]  G. Breier,et al.  Coordinate expression of vascular endothelial growth factor receptor‐1 (fit‐1) and its ligand suggests a paracrine regulation of murine vascular development , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[102]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[103]  M. Matsumoto,et al.  Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[104]  C F Dewey,et al.  Vascular endothelial cells respond to spatial gradients in fluid shear stress by enhanced activation of transcription factors. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[105]  M. Pepper,et al.  Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. , 1997, Cytokine & growth factor reviews.

[106]  L. Pardanaud,et al.  Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. , 1989, Development.

[107]  L Orci,et al.  In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices , 1983, The Journal of cell biology.

[108]  P. Eggli,et al.  First blood vessels in the avian neural tube are formed by a combination of dorsal angioblast immigration and ventral sprouting of endothelial cells. , 1996, Developmental biology.

[109]  J. Folkman.  Tumor angiogenesis. , 1985, Advances in cancer research.

[110]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[111]  G. Yancopoulos,et al.  Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.

[112]  T. Sato,et al.  Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[113]  C. R. Stockard.  The origin of blood and vascular endothelium in embryos without a circulation of the blood and in the normal embryo , 1915 .

[114]  K.,et al.  Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[115]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. , 1999, Current topics in microbiology and immunology.

[116]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[117]  S. Schwartz,et al.  Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo. , 1991, Developmental biology.

[118]  F. Dieterlen‐Lièvre,et al.  Vasculogenesis in the early quail blastodisc as studied with a monoclonal antibody recognizing endothelial cells. , 1987, Development.

[119]  D. Luton,et al.  Two distinct endothelial lineages in ontogeny, one of them related to hemopoiesis. , 1996, Development.

[120]  L. Williams,et al.  Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[121]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[122]  L. Brown,et al.  VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. , 1996, The American journal of physiology.

[123]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[124]  W. His.  Untersuchungen über die erste Anlage des Wirbelthierleibes : die erste Entwickelung des Hühnchens im Ei / , 1868 .

[125]  P H Burri,et al.  Scanning electron microscope study of the developing microvasculature in the postnatal rat lung , 1986, The Anatomical record.

[126]  A. Kulkarni,et al.  Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. , 1995, Development.

[127]  G. Breier,et al.  Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo. , 1995, Developmental biology.

[128]  R. Crystal,et al.  Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor. , 1998, Human gene therapy.